Stay updated on Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    No additions or deletions were detected; only metadata updates (e.g., the 'Results First Posted' date) and minor formatting/UI refinements. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-10-27T21:12:56.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Added a funding/operating status notice and a new version tag (v3.2.0); removed two specific cancer diagnoses and an older version tag (v3.1.0).
    Difference
    2%
    Check dated 2025-10-06T08:48:39.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no other page content or data appears to be altered.
    Difference
    0.0%
    Check dated 2025-09-29T07:35:00.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Version updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed, with no substantive content changes.
    Difference
    0.1%
    Check dated 2025-09-14T23:13:03.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.1%
    Check dated 2025-09-07T19:51:30.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility and location information, as well as additional resources related to various gastrointestinal diseases and neoplasms. Notably, the names of specific drugs and conditions have been revised, reflecting a shift in focus towards more current medical topics.
    Difference
    4%
    Check dated 2025-08-31T12:34:59.000Z thumbnail image

Stay in the know with updates to Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Surufatinib and Tislelizumab Combination in Solid Tumors Clinical Trial page.